Adverse effects of the implantable ranibizumab system may undermine its benefits
- Posted on: May 10 2023
- Leave a response
The ranibizumab Port Delivery System (PDS) for neovascular age-related macular degeneration (AMD) may involve more risk of adverse effects than monthly injections.
Source: AAO
Posted in: Uncategorized
